Search clinical trials for: EE30/DRSP (Yasmin, BAY86-5131)

Total 36 results

Bayer

Completed

Yasmin Post Marketing Surveillance

Contraception

Korea, Republic of
Bayer

Completed

Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

Contraception

Saudi Arabia, Jordan, Lebanon, Bahrain, Kuwait, Oman, Qatar, Hungary, Albania, Egypt, Kenya, Macedonia, The Former Yugoslav Republic of, United Arab Emirates
Bayer

Completed

LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study

Contraception

Belgium, United States, Russian Federation, Germany, Austria
Bayer

Completed

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being (COSME)

Contraception

Italy
Bayer

Completed

YAZ Post-marketing Surveillance in Japan

Dysmenorrhea

Japan
Bayer

Completed

Regulatory Post Marketing Surveillance Study on YAZ

Contraception | Acne | Premenstrual Syndrome

Korea, Republic of
Bayer

Completed

Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea

Dysmenorrhea

Japan
Bayer

Completed

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

Contraception

Netherlands, Canada, Germany
Bayer

Completed

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

Contraception

China
Bayer

Withdrawn

To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

Dysmenorrhea
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Bayer

Completed

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Premenstrual Dysphoric Disorder ( PMDD)

China
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)

Contraception

Germany
Bayer

Withdrawn

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

Contraception
Organon and Co

Completed

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

Contraception
Bayer

Completed

Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.

Healthy
Bayer

Completed

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Acne Vulgaris

United States
Bayer

Completed

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Acne Vulgaris

United States
Bayer

Completed

Efficacy and Safety Oral Contraceptive Study

Contraception
Bayer

Completed

To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives (DOC)

Contraception

Poland
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

Contraception

Netherlands
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Bayer

Completed

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception

Contraception

Mexico
Bayer

Completed

Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

Endometriosis

Japan
Bayer

Completed

Angeliq Regulatory Post Marketing Surveillance (Angeliq rPMS)

Osteoporosis, Postmenopausal | Postmenopausal Period

Korea, Republic of
Bayer

Completed

Comparative Trial in Hormone Withdrawal Associated Symptoms

Oral Contraceptive

Switzerland, Portugal, Chile, Italy, Korea, Republic of, Venezuela, Philippines, Colombia, Thailand, Argentina, Germany, Russian Federation, United Kingdom, Czech Republic
Bayer

Completed

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Vasomotor Symptoms

China
Bayer

Completed

Efficacy and Tolerability of Angeliq in Thai Women

Postmenopause
Organon and Co

Completed

A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

Contraception
Bayer

Completed

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Contraceptives, Oral

Netherlands
Bayer

Completed

Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

Contraception

Germany
Bayer

Completed

GA YAZ ACNE in China Phase III

Acne Vulgaris

China
Bayer

Completed

LCS16 vs. COC User Satisfaction and Tolerability Study

Contraception

Russian Federation
Bayer

Completed

Bleeding Pattern Study

Oral Contraceptive

Germany
Bayer

Completed

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Healthy

Germany

3

Subscribe